Kaili Wu

机构：Guangdong Pharmaceutical University, Sichuan University, State Administration of Traditional Chinese Medicine of the People's Republic of China, West China Second University Hospital of Sichuan University, Key Laboratory of Guangdong Province, Integrated Chinese Medicine (China) · ORCID：0000-0003-0535-3836

发表论文 22 篇 · 总被引 231 次 · h-index 9

代表论文

• MicroRNA-24-3p alleviates cardiac fibrosis by suppressing cardiac fibroblasts mitophagy via downregulating PHB2 (2022 · Pharmacological Research · 被引 52)
• The Effects of Tai Chi on Lung Function, Exercise Capacity and Health Related Quality of Life for Patients With Chronic Obstructive Pulmonary Disease: A Pilot Study (2018 · Heart Lung and Circulation · 被引 35)
• Fufang Zhenzhu Tiaozhi (FTZ) capsule ameliorates diabetes-accelerated atherosclerosis via suppressing YTHDF2-mediated m6A modification of SIRT3 mRNA (2023 · Journal of Ethnopharmacology · 被引 22)
• Associations between Serum Aflatoxin-B1 and Anemia in Pregnant Women: Evidence from Guangxi Zhuang Birth Cohort in China (2021 · Toxins · 被引 19)
• The plasma level of mCRP is linked to cardiovascular disease in antineutrophil cytoplasmic antibody-associated vasculitis (2020 · Arthritis Research & Therapy · 被引 17)
• BAG3 Alleviates Atherosclerosis by Inhibiting Endothelial-to-Mesenchymal Transition via Autophagy Activation (2022 · Genes · 被引 15)